HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gianluca Franceschini Selected Research

Gianluca Franceschini Research Topics

Disease

61Breast Neoplasms (Breast Cancer)
03/2024 - 01/2006
24Neoplasms (Cancer)
05/2023 - 03/2010
5Neoplasm Metastasis (Metastasis)
05/2023 - 10/2003
5Margins of Excision
01/2020 - 01/2015
4Triple Negative Breast Neoplasms
05/2023 - 01/2019
4Noninfiltrating Intraductal Carcinoma (DCIS)
04/2023 - 05/2008
3Lymphedema (Milroy Disease)
12/2021 - 01/2020
3Cicatrix (Scar)
10/2020 - 01/2019
2Lobular Carcinoma
03/2022 - 01/2009
2Carcinoma in Situ
03/2022 - 01/2022
2Disease Progression
01/2022 - 12/2021
2Carcinoma (Carcinomatosis)
01/2022 - 01/2019
2Necrosis
12/2020 - 11/2019
2Ischemia
01/2020 - 01/2019
2Pathologic Complete Response
01/2020 - 12/2016
2Infections
11/2019 - 01/2019
1Inflammatory Breast Neoplasms
01/2024
1Lung Neoplasms (Lung Cancer)
10/2023
1Ductal Carcinoma
03/2022
1Alopecia (Baldness)
01/2022
1Brain Neoplasms (Brain Tumor)
01/2022
1Eczema
01/2022
1Hemorrhage
01/2022
1Breast Carcinoma In Situ
01/2022
1Mammary Paget's Disease
01/2022
1Pruritus (Itching)
01/2022
1COVID-19
01/2021
1Adult-Onset Still's Disease
07/2020
1Paraneoplastic Syndromes (Paraneoplastic Syndrome)
07/2020
1Heart Failure
07/2020
1Seroma
01/2020
1Pain (Aches)
08/2019
1Wounds and Injuries (Trauma)
07/2019
1Ovarian Neoplasms (Ovarian Cancer)
01/2019
1Paresthesia (Dysesthesia)
01/2019

Drug/Important Bio-Agent (IBA)

6purified rayonIBA
10/2023 - 01/2015
4Phenobarbital (Luminal)FDA Link
01/2023 - 09/2014
4Hormones (Hormone)IBA
11/2022 - 09/2014
3human ERBB2 proteinIBA
05/2023 - 09/2014
3AnthracyclinesIBA
01/2022 - 01/2012
34-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA
01/2016 - 01/2015
2Biomarkers (Surrogate Marker)IBA
08/2021 - 10/2004
2palbociclibIBA
12/2020 - 01/2020
2Docetaxel (Taxotere)FDA Link
10/2014 - 01/2012
1tiboloneIBA
12/2023
1Biocompatible Materials (Biomaterials)IBA
10/2023
1Estrogen ReceptorsIBA
05/2023
1Progesterone Receptors (Progesterone Receptor)IBA
05/2023
1Estrogens (Estrogen)FDA Link
04/2023
1Endocrine DisruptorsIBA
04/2023
1anlotinibIBA
01/2023
1Immune Checkpoint InhibitorsIBA
01/2023
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2023
1hydroxide ionIBA
03/2022
1Vitamin DFDA LinkGeneric
03/2022
1ErbB Receptors (EGF Receptor)IBA
01/2022
1pyrotinibIBA
01/2022
1Capecitabine (Xeloda)FDA Link
01/2022
1taxaneIBA
01/2022
1MicroRNAs (MicroRNA)IBA
08/2021
1apatinibIBA
05/2021
1Vinorelbine (Navelbine)FDA LinkGeneric
05/2021
1Fulvestrant (Faslodex)FDA Link
12/2020
1exemestane (Aromasin)FDA Link
12/2020
1Cyclin-Dependent Kinase 4IBA
12/2020
1EverolimusFDA Link
12/2020
1SolutionsIBA
01/2020
1Oral ContraceptivesIBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
11/2019
1Aromatase InhibitorsIBA
01/2019
1Selective Estrogen Receptor Modulators (SERM)IBA
01/2019
1PlasticsIBA
01/2019

Therapy/Procedure

24Mastectomy (Mammectomy)
05/2023 - 07/2006
18Neoadjuvant Therapy
01/2024 - 10/2004
17Radiotherapy
01/2022 - 10/2004
15Segmental Mastectomy (Lumpectomy)
05/2023 - 01/2008
13Therapeutics
03/2024 - 05/2008
11Drug Therapy (Chemotherapy)
01/2022 - 10/2003
6Mammaplasty (Breast Reconstruction)
01/2022 - 01/2016
3Lymph Node Excision (Lymph Node Dissection)
01/2022 - 03/2016
3Contraindications
01/2022 - 01/2019
3Adjuvant Radiotherapy
07/2020 - 03/2010
2Adjuvant Chemotherapy
01/2022 - 01/2018
2Prophylactic Mastectomy
01/2020 - 01/2019
2Tattooing
11/2019 - 01/2018
2Radical Mastectomy
03/2015 - 01/2008
2Conservative Treatment
03/2010 - 01/2006
1Operative Surgical Procedures
01/2022
1Immunotherapy
06/2021
1Preoperative Exercise
04/2021
1Metastasectomy
03/2021
1Breast Implants (Breast Implant)
10/2020
1Length of Stay
01/2020
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2020
1Operative Time
01/2020
1Precision Medicine
07/2019
1Chemoprevention
01/2019
1Salpingo-oophorectomy
01/2019
1Prostheses and Implants (Prosthesis)
01/2019